Autologous Blood Pleurodesis: What Is the Optimal Time Interval and Amount of Blood?


Journal

The Thoracic and cardiovascular surgeon
ISSN: 1439-1902
Titre abrégé: Thorac Cardiovasc Surg
Pays: Germany
ID NLM: 7903387

Informations de publication

Date de publication:
12 2022
Historique:
pubmed: 15 4 2021
medline: 22 12 2022
entrez: 14 4 2021
Statut: ppublish

Résumé

Air leak is the most common complication after lung resection and leads to increased length of hospital (LOH) stay or patient discharge with a chest tube. Management by autologous blood patch pleurodesis (ABPP) is controversial because few studies exist, and the technique has yet to be standardized. We retrospectively reviewed patients undergoing ABPP for prolonged air leak (PAL) following lobectomy in three centers, between January 2014 and December 2019. They were divided into two groups: Group A, 120 mL of blood infused; Group B, 60 mL. Propensity score-matched (PSM) analysis was performed, and 23 patients were included in each group. Numbers and success rates of blood patch, time to cessation of air leak, time to chest tube removal, reoperation, LOH, and complications were examined. Univariate and multivariate analysis of variables associated with an increased risk of air leak was performed. After the PSM, 120 mL of blood is statistically significant in reducing the number of days before chest tube removal after ABPP (2.78 vs. 4.35), LOH after ABPP (3.78 vs. 10.00), and LOH (8.78 vs. 15.17). Complications (0 vs. 4) and hours until air leak cessation (6.83 vs. 3.91, range 1-13) after ABPP were also statistically different ( In our experience, 120 mL is the optimal amount of blood and the procedure can be repeated every 24 hours with the chest tube clamped.

Sections du résumé

BACKGROUND
Air leak is the most common complication after lung resection and leads to increased length of hospital (LOH) stay or patient discharge with a chest tube. Management by autologous blood patch pleurodesis (ABPP) is controversial because few studies exist, and the technique has yet to be standardized.
METHODS
We retrospectively reviewed patients undergoing ABPP for prolonged air leak (PAL) following lobectomy in three centers, between January 2014 and December 2019. They were divided into two groups: Group A, 120 mL of blood infused; Group B, 60 mL. Propensity score-matched (PSM) analysis was performed, and 23 patients were included in each group. Numbers and success rates of blood patch, time to cessation of air leak, time to chest tube removal, reoperation, LOH, and complications were examined. Univariate and multivariate analysis of variables associated with an increased risk of air leak was performed.
RESULTS
After the PSM, 120 mL of blood is statistically significant in reducing the number of days before chest tube removal after ABPP (2.78 vs. 4.35), LOH after ABPP (3.78 vs. 10.00), and LOH (8.78 vs. 15.17). Complications (0 vs. 4) and hours until air leak cessation (6.83 vs. 3.91, range 1-13) after ABPP were also statistically different (
CONCLUSION
In our experience, 120 mL is the optimal amount of blood and the procedure can be repeated every 24 hours with the chest tube clamped.

Identifiants

pubmed: 33851409
doi: 10.1055/s-0041-1727129
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

671-676

Informations de copyright

Thieme. All rights reserved.

Déclaration de conflit d'intérêts

None declared.

Auteurs

Alessio Campisi (A)

Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.
Department of Thoracic Diseases, Thoracic Surgery Unit, University of Bologna, G.B. Morgagni-L. Pierantoni Hospital, Forlì, Italy.

Andrea Dell'Amore (A)

Department of Cardiothoracic Surgery and Vascular Sciences, Division of Thoracic Surgery, Padua University Hospital, University of Padua, Via Giustiniani 1, Padua (PD), Italy.

Yonghui Zhang (Y)

Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.

Zhitao Gu (Z)

Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.

Angelo Paolo Ciarrocchi (AP)

Department of Thoracic Diseases, Thoracic Surgery Unit, University of Bologna, G.B. Morgagni-L. Pierantoni Hospital, Forlì, Italy.

Eleonora Faccioli (E)

Department of Cardiothoracic Surgery and Vascular Sciences, Division of Thoracic Surgery, Padua University Hospital, University of Padua, Via Giustiniani 1, Padua (PD), Italy.

Luca Bertolaccini (L)

Department of Thoracic Surgery, European Institute of Oncology IRCCS, Milan, Italy.

Federico Rea (F)

Department of Cardiothoracic Surgery and Vascular Sciences, Division of Thoracic Surgery, Padua University Hospital, University of Padua, Via Giustiniani 1, Padua (PD), Italy.

Franco Stella (F)

Department of Thoracic Diseases, Thoracic Surgery Unit, University of Bologna, G.B. Morgagni-L. Pierantoni Hospital, Forlì, Italy.

Wentao Fang (W)

Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH